Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of the Liver
2024-10-01
|
| Series: | Clinical and Molecular Hepatology |
| Subjects: | |
| Online Access: | http://e-cmh.org/upload/pdf/cmh-2024-0469.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846163790665613312 |
|---|---|
| author | Antonio Bertoletti Anthony T Tan |
| author_facet | Antonio Bertoletti Anthony T Tan |
| author_sort | Antonio Bertoletti |
| collection | DOAJ |
| format | Article |
| id | doaj-art-c8b5a2f7e91b47a980e5c427222eefa9 |
| institution | Kabale University |
| issn | 2287-2728 2287-285X |
| language | English |
| publishDate | 2024-10-01 |
| publisher | Korean Association for the Study of the Liver |
| record_format | Article |
| series | Clinical and Molecular Hepatology |
| spelling | doaj-art-c8b5a2f7e91b47a980e5c427222eefa92024-11-19T00:30:14ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2024-10-0130472873410.3350/cmh.2024.04691953Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”Antonio Bertoletti0Anthony T Tan1 Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singaporehttp://e-cmh.org/upload/pdf/cmh-2024-0469.pdfliver canceradoptive t cell therapyhbv |
| spellingShingle | Antonio Bertoletti Anthony T Tan Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting” Clinical and Molecular Hepatology liver cancer adoptive t cell therapy hbv |
| title | Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting” |
| title_full | Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting” |
| title_fullStr | Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting” |
| title_full_unstemmed | Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting” |
| title_short | Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting” |
| title_sort | engineering hbv specific t cells for the treatment of hbv related hcc and hbv infection past present and future editorial on genetically modified redirected t cells target hepatitis b surface antigen positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting |
| topic | liver cancer adoptive t cell therapy hbv |
| url | http://e-cmh.org/upload/pdf/cmh-2024-0469.pdf |
| work_keys_str_mv | AT antoniobertoletti engineeringhbvspecifictcellsforthetreatmentofhbvrelatedhccandhbvinfectionpastpresentandfutureeditorialongeneticallymodifiedredirectedtcellstargethepatitisbsurfaceantigenpositivehepatocytesandhepatocellularcarcinomalesionsinaclinicalsetting AT anthonyttan engineeringhbvspecifictcellsforthetreatmentofhbvrelatedhccandhbvinfectionpastpresentandfutureeditorialongeneticallymodifiedredirectedtcellstargethepatitisbsurfaceantigenpositivehepatocytesandhepatocellularcarcinomalesionsinaclinicalsetting |